Thus, the results of the present study provide further evidence that the factors linking TCF7L2 gene polymorphism to T2DM may lie in two of the major mechanisms of the pathophysiology of disease, namely, defects in GLP-1 mediated insulin secretion at a pancreatic level, and GLP-1 peripheral action. This evidence concerns the gene TCF7L2 and type 2 diabetes mellitus.